Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Talotrexin in Treating Patients With Advanced or Recurrent Solid Tumors

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00098514
First received: December 7, 2004
Last updated: July 23, 2008
Last verified: January 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given